# Christian Karime

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/christian-karime/

## Facts

| Field | Value |
| --- | --- |
| Citations | 211 |
| Field | Inflammatory Bowel Disease |
| h-index | 8 |
| i10-index | 7 |
| OpenAlex ID | https://openalex.org/A5026700139 |
| ORCID iD | 0000-0003-0383-613X |
| Works | 72 |

## Researcher papers

- [Longitudinal Strain Reflects Ventriculoarterial Coupling Rather Than Mere Contractility in Rat Models of Hemodynamic Overload–Induced Heart Failure](https://scholariq.org/papers/longitudinal-strain-reflects-ventriculoarterial-coupling-rather-than-mere/)
- [Myocardial Work Index: A Marker of Left Ventricular Contractility in Pressure- or Volume Overload-Induced Heart Failure](https://scholariq.org/papers/myocardial-work-index-a-marker-of-left-ventricular-contractility-in-pressure-or/)
- [<i>Lactobacillus rhamnosus</i> sepsis, endocarditis and septic emboli in a patient with ulcerative colitis taking probiotics](https://scholariq.org/papers/i-lactobacillus-rhamnosus-i-sepsis-endocarditis-and-septic-emboli-in-a-patient/)
- [Incomplete structural reverse remodeling from late-stage left ventricular hypertrophy impedes the recovery of diastolic but not systolic dysfunction in rats](https://scholariq.org/papers/incomplete-structural-reverse-remodeling-from-late-stage-left-ventricular/)
- [Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib](https://scholariq.org/papers/response-to-upadacitinib-in-patients-with-inflammatory-bowel-disease-previously/)
- [Pharmacotherapeutic options for pancreatic ductal adenocarcinoma](https://scholariq.org/papers/pharmacotherapeutic-options-for-pancreatic-ductal-adenocarcinoma/)
- [Tilsotolimod: an investigational synthetic toll-like receptor 9 (TLR9) agonist for the treatment of refractory solid tumors and melanoma](https://scholariq.org/papers/tilsotolimod-an-investigational-synthetic-toll-like-receptor-9-tlr9-agonist-for/)
- [Utility of a Third Heplisav-B Dose in Patients With Inflammatory Bowel Disease Without Immunity After 2-Dose Heplisav-B Vaccination](https://scholariq.org/papers/utility-of-a-third-heplisav-b-dose-in-patients-with-inflammatory-bowel-disease/)
- [Association Between Coronavirus Disease 2019 and Acute Complicated Diverticulitis](https://scholariq.org/papers/association-between-coronavirus-disease-2019-and-acute-complicated/)
- [Validation of prediction tools for GI bleeding in patients on dual anti-platelet therapy after percutaneous coronary intervention](https://scholariq.org/papers/validation-of-prediction-tools-for-gi-bleeding-in-patients-on-dual-anti-platelet/)
- [Improved Outcomes Associated With Teduglutide Use in Patients With Both Short Bowel Syndrome and Crohn’s Disease](https://scholariq.org/papers/improved-outcomes-associated-with-teduglutide-use-in-patients-with-both-short/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Gastrointestinal Bleeding Diagnosis and Treatment](https://scholariq.org/topics/gastrointestinal-bleeding-diagnosis-and-treatment/)
- [Gastrointestinal disorders and treatments](https://scholariq.org/topics/gastrointestinal-disorders-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.